Tekla Healthcare 投资者（纽约证券交易所代码：HQH）的空头利息减少了94.6％

Tekla Healthcare Investors (NYSE:HQH – Get Rating) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 5,500 shares, a decrease of 94.6% from the February 28th total of 101,400 shares. Based on an average daily volume of 156,500 shares, the short-interest ratio is currently 0.0 days.

Tekla Healthcare Investors Stock Performance

Shares of Tekla Healthcare Investors stock traded up $0.12 during trading hours on Monday, hitting $17.26. The company's stock had a trading volume of 87,621 shares, compared to its average volume of 143,100. Tekla Healthcare Investors has a twelve month low of $16.76 and a twelve month high of $22.31. The firm has a fifty day moving average of $18.22 and a 200-day moving average of $18.37.

Tekla Healthcare Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 31st. Investors of record on Monday, February 27th will be issued a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 9.73%. The ex-dividend date of this dividend is Friday, February 24th. This is an increase from Tekla Healthcare Investors's previous quarterly dividend of $0.39.

Institutional Investors Weigh In On Tekla Healthcare Investors

Institutional investors and hedge funds have recently modified their holdings of the company. CoreCap Advisors LLC purchased a new stake in shares of Tekla Healthcare Investors in the 4th quarter valued at $32,000. Northwestern Mutual Wealth Management Co. increased its holdings in Tekla Healthcare Investors by 70.1% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,635 shares of the financial services provider's stock worth $47,000 after purchasing an additional 1,086 shares during the period. Money Concepts Capital Corp purchased a new stake in Tekla Healthcare Investors during the 4th quarter worth about $132,000. Captrust Financial Advisors purchased a new stake in Tekla Healthcare Investors during the 2nd quarter worth about $134,000. Finally, D.A. Davidson & CO. purchased a new stake in Tekla Healthcare Investors during the 3rd quarter worth about $180,000. Hedge funds and other institutional investors own 17.30% of the company's stock.

Tekla Healthcare Investors Company Profile

(Get Rating)

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Recommended Stories

• Get a free copy of the StockNews.com research report on Tekla Healthcare Investors (HQH)
• Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
• 3 Financials The Insiders Are Buying
• Can Carnival Cruise Lines Set Sail For New Highs?
• If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
• BioNTech Is Ripe For A Rebound In 2023

Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.